SeekingAlpha · Sep 24, 2026
BlackRock Capital Allocation Term Trust Rights Offering Quick Notes
BlackRock Capital Allocation Term Trust announced a rights offering with a conservative 1-for-5 ratio and a 98.5% NAV floor. Read why BCAT CEF is a hold.
NYSE · BCAT
Financial Services · Asset Management
$13.71
Up+$0.06 (+0.44%)
Updated Oct 7, 2026, 10:06 PM
SID Score
4.6/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · BCAT
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
BCAT closed at $13.71 after 21 trading sessions, down 14.74% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $13.59 | $13.74 | $13.57 | $13.71 | 773.33K |
| Oct 5, 2026 | $13.68 | $13.71 | $13.56 | $13.64 | 770.25K |
| Oct 2, 2026 | $13.74 | $13.75 | $13.58 | $13.73 | 520.43K |
| Oct 1, 2026 | $13.86 | $13.86 | $13.54 | $13.59 | 1.46M |
| Sep 30, 2026 | $13.70 | $13.83 | $13.68 | $13.70 | 1.27M |
| Sep 29, 2026 | $13.55 | $13.6813 | $13.425 | $13.67 | 1.18M |
| Sep 28, 2026 | $13.60 | $13.65 | $13.51 | $13.56 | 838.03K |
| Sep 25, 2026 | $13.88 | $14.0454 | $13.585 | $13.70 | 1.62M |
| Sep 24, 2026 | $13.91 | $14.195 | $13.635 | $13.88 | 1.83M |
| Sep 23, 2026 | $14.20 | $14.20 | $13.94 | $13.95 | 1.2M |
| Sep 22, 2026 | $14.15 | $14.1997 | $14.065 | $14.18 | 1.55M |
| Sep 21, 2026 | $14.28 | $14.32 | $14.135 | $14.14 | 1.24M |
| Sep 18, 2026 | $14.30 | $14.40 | $14.24 | $14.34 | 1.3M |
| Sep 17, 2026 | $14.28 | $14.42 | $14.28 | $14.33 | 1.02M |
| Sep 16, 2026 | $14.19 | $14.3236 | $14.085 | $14.17 | 1.74M |
| Sep 15, 2026 | $14.40 | $14.498 | $14.15 | $14.19 | 1.43M |
| Sep 14, 2026 | $14.60 | $14.75 | $14.43 | $14.70 | 1.88M |
| Sep 11, 2026 | $15.10 | $15.20 | $14.40 | $14.80 | 5.11M |
| Sep 10, 2026 | $15.89 | $16.0367 | $15.85 | $15.91 | 898.58K |
| Sep 9, 2026 | $16.08 | $16.13 | $15.965 | $15.99 | 568.62K |
| Sep 8, 2026 | $15.98 | $16.09 | $15.95 | $16.08 | 357.55K |
The latest Smart Investors Daily articles mentioning BCAT.
Company
Market Activity
Research & News
BCAT research
Company profile and research snapshot.
BlackRock Capital Allocation Trust is a non-diversified, closed-end management investment company. The investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation.
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
SeekingAlpha · Sep 24, 2026
BlackRock Capital Allocation Term Trust announced a rights offering with a conservative 1-for-5 ratio and a 98.5% NAV floor. Read why BCAT CEF is a hold.
Yahoo · Sep 10, 2026
NEW YORK, September 10, 2026--BlackRock Capital Allocation Term Trust (NYSE: BCAT) (the "Fund") today announced the terms of transferable rights ("Rights") to be issued to the holders of the Fund's common shares of beneficial interest, par value $0.001 per share ("Shares"), as of September 25, 2026 (the "Record Date"). Holders of Rights will be entitled to subscribe for additional Shares (the "Offer") at a discount to the net asset value ("NAV") of the Shares.
SeekingAlpha · Aug 20, 2026
A year ago, the Guggenheim Strategic Opportunity fund (GOF) was on top of the CEF world, trading at a 30% market price premium over its NAV.
SeekingAlpha · Aug 3, 2026
BCAT CEF analysis: tech rally supports yield, but ROC-heavy payouts risk NAV erosion. Learn why itâs a tactical hold, not core.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning BCAT.